| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718566A Ferulaic acid and its sodium salt used for preventing and treating senile dementia medicine |
| 01/11/2006 | CN1718223A Medicine for treating osteoporosis contg. astraglus base and stanozolol |
| 01/11/2006 | CN1718194A Oligonucleotide medicine for treating myophagism |
| 01/11/2006 | CN1718193A Total secondary ginseng glucoside medicine composition, its prepn. method and application in preparing medicine for treating myocardial ischemia and hemorrhagic shock |
| 01/11/2006 | CN1718192A Powder injection of american ginseng glycol saponin, and its prepn. method |
| 01/11/2006 | CN1718191A Total secondary ginseng glucoside oral disintegration tablets prepn. method and application thereof |
| 01/11/2006 | CN1718190A Nux vomica alkaloid liposome, and its prepn. method |
| 01/11/2006 | CN1718189A Anticarcinogen composition |
| 01/11/2006 | CN1718188A Terazosin hydrochloride dripping pills, and its prepn. method |
| 01/11/2006 | CN1718187A Indapamide dripping pills, and its prepn. method |
| 01/11/2006 | CN1718186A Anethol trithione dripping pills, and its preparing method |
| 01/11/2006 | CN1718185A Long-acting anethol trithione prepn. and its prepn. method |
| 01/11/2006 | CN1718184A Neo-garcinolic acid composition having anti-neoplastic activity, prepn. method and use thereof |
| 01/11/2006 | CN1718183A Neo-garcinolic acid prepn. for injection use, prepn. method and use thereof |
| 01/11/2006 | CN1718182A Use of vegetable flavonoid |
| 01/11/2006 | CN1718181A Medicine of (4-alkynyl)-aromatic keto-acid compounds for treating chronic obstructive lung diseases |
| 01/11/2006 | CN1718081A Formula for biological agent for birds |
| 01/11/2006 | CN1718020A Method for preparing milk tablets contg micron ginseng and antler etc. with tonifying-kidney and eliminating-fatigue functions |
| 01/11/2006 | CN1236067C Preparation process of rise bran polysaccharose kind active component |
| 01/11/2006 | CN1235914C Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative |
| 01/11/2006 | CN1235911C Multiple cytokine-antibody complexes |
| 01/11/2006 | CN1235908C 16,17-carbocyclic condensed steroid compounds having seletive estrogenic activity |
| 01/11/2006 | CN1235905C Rhodiola sacra glycoside derivative and its preparation method and use |
| 01/11/2006 | CN1235901C Compounds of podophyllotoxins, application and preparation method |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235890C Thizaolyl amide derivatives |
| 01/11/2006 | CN1235887C Preparation method of xazolyl alcohol derivatives |
| 01/11/2006 | CN1235884C Antifungal compound of substitution benzyl triazole alcohols and preparing process thereof |
| 01/11/2006 | CN1235882C Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235641C Medicinal aerosol formulation, its preparing process, use and inhaler containing same |
| 01/11/2006 | CN1235638C Activated protein C formulations |
| 01/11/2006 | CN1235630C Chinese medicine paste for curing osteoarthropathy and preparing method |
| 01/11/2006 | CN1235617C Skin lightening composition containing magnesium ascorbyl phosphate and uniontan-U34 TM (extract formulation of cucumber extract and lemon extract) |
| 01/11/2006 | CN1235614C Chinese traditional medicine composition for treating digestive system cancer and its preparing method |
| 01/11/2006 | CN1235607C Ointment for treating wound sore and its preparation method |
| 01/11/2006 | CN1235606C Vaginitis-treating compound Chinese and Western medicine preparation |
| 01/11/2006 | CN1235600C Phenergan bile tablet and preparing process thereof |
| 01/11/2006 | CN1235597C Wound nursing medicinal composition |
| 01/11/2006 | CN1235596C Spray for treating asthma and its preparing method |
| 01/11/2006 | CN1235595C Chitin soft capsule and preparing method thereof |
| 01/11/2006 | CN1235594C Cell growth regulating factor Q and its prepn process |
| 01/11/2006 | CN1235593C Regulatory factor T for cell growth, and its prepn. method |
| 01/11/2006 | CN1235592C Glycyrrhizin triple composition nano micro particle and its preparing method |
| 01/11/2006 | CN1235591C Composition for preventing and treating yellow dysentery of piglet |
| 01/11/2006 | CN1235590C Phenasteroid gel preparation |
| 01/11/2006 | CN1235589C Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 01/11/2006 | CN1235588C Almitil intravenous injection and its preparing method |
| 01/11/2006 | CN1235587C 9-nitrocamptothecin solid dispersant and preparation method |
| 01/11/2006 | CN1235586C Improved releasing composition and use thereof |
| 01/11/2006 | CN1235585C Use of berberine as anti fungus medicine synergist |
| 01/11/2006 | CN1235584C Sustained release tablet of matrine and its preparing method |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/11/2006 | CN1235582C Medicines for preventing and treating retina and cornea blood vessel diseases |
| 01/11/2006 | CN1235581C Method for preparing Sanguis Draxonis flavoniod formulation and its quality controlling method |
| 01/11/2006 | CN1235580C Total gambogic acid preparation and its preparing method |
| 01/11/2006 | CN1235579C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/11/2006 | CN1235578C Fumaric acid microtablets |
| 01/11/2006 | CN1235577C Health products using L-arginine as raw materials |
| 01/11/2006 | CN1235576C Slow-released dosage form of sodium ferulate and preparation process thereof |
| 01/11/2006 | CN1235575C Coenzyme Q10 aseptic free-drying preparation for injection and its preparing method |
| 01/11/2006 | CN1235574C Use of central China fruit of Chinese magnoliavine ketone in preparing medicine or food for preventing and treating Alzheimer's disease |
| 01/11/2006 | CN1235571C Chitosan and fibroin mixed microsphere, its usage and preparing process |
| 01/11/2006 | CN1235568C Aqueous-based pharmaceutical composition |
| 01/11/2006 | CN1235567C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 01/11/2006 | CN1235566C Drondearone pharmaceutical composition for external gastrointestinal-tract administration |
| 01/11/2006 | CN1235559C Improvement of moisture retention ability of skin |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984667 Synergistic proteoglycan compositions for inflammatory conditions |
| 01/10/2006 | US6984666 Polycosanols from Ericerus pela wax |
| 01/10/2006 | US6984665 Administering 4-chloro-1-(p-(2-hydroxyethoxy)phenyl)-1,2-diphenyl-1-butene or a geometric isomer, a stereoisomer, a salt, an ester thereof or a metabolite thereof |
| 01/10/2006 | US6984664 Reduce side effect; analgesics |
| 01/10/2006 | US6984663 Cyclohexyl sulphones |
| 01/10/2006 | US6984661 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR) |
| 01/10/2006 | US6984660 To treat and/or prevent hypertension, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, and endothelial dysfunction or endothelial damage as a consequence of atherosclerotic processes or diabetes |
| 01/10/2006 | US6984659 Huntington disorders; central nervous system disorders |
| 01/10/2006 | US6984658 Oligo/polysuccinimides, process for producing thereof and their use |
| 01/10/2006 | US6984657 Indole derivatives as MCP-1 receptor antagonists |
| 01/10/2006 | US6984656 Core modified porphyrins |
| 01/10/2006 | US6984655 Photodynamic therapy for selectively closing neovasa in eyeground tissue |
| 01/10/2006 | US6984654 Cancer treatments and pharmaceutical compositions therefor |
| 01/10/2006 | US6984653 useful as a growth factor receptor tyrosine kinase HER2 (Human epidermal growth factor receptor-2) inhibitor; for treating cancer |
| 01/10/2006 | US6984652 useful for the treatment or prophylaxis of bacterial infections in mammals |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984650 Comprises phosphorescence and fluorescence resonance energy transfer; binding chenodeoxycholic acid to farnesoid X receptors; for regulating cholesterol absorption; for treatment of obesity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984646 suitable for the preparation of medicaments for the treatment of diseases associated with p38 MAP kinase such as atherosclerosis, diabetes, adult respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, fever etc |
| 01/10/2006 | US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes |
| 01/10/2006 | US6984644 Treatment of skin disorders using thieno[2,3-D]pyrimidinediones |
| 01/10/2006 | US6984643 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984640 Antiparasitic artemisinin derivatives (endoperoxides) |
| 01/10/2006 | US6984639 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |